0 Comments
0 Shares
115 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Europe Molecular Diagnostics Market Outlook 2034: Trends, Growth, and OpportunitiesThe Europe molecular diagnostics market is witnessing significant growth, driven by the increasing burden of infectious diseases and the rapid evolution of personalized medicine. Valued at US$ 5.9 billion in 2023, the market is projected to expand at a CAGR of 10.2% from 2024 to 2034, reaching an estimated US$ 17.3 billion by the end of the forecast period. This growth highlights the rising...0 Comments 0 Shares 184 Views 0 Reviews
-
Head and Neck Cancer Market: How Is Liquid Biopsy and Molecular Diagnostics Creating the Precision Monitoring Revenue Stream?Liquid biopsy technologies for head and neck cancer — the circulating tumor DNA (ctDNA), circulating tumor cells (CTC), and HPV DNA detection assays enabling non-invasive treatment monitoring, recurrence detection, and minimal residual disease assessment — create the diagnostic companion market segment, with the Head and Neck Cancer Market reflecting molecular diagnostics as the...0 Comments 0 Shares 94 Views 0 Reviews
-
Hybridization-based Molecular Diagnostics market Competitive Intelligence Report 2026"Hybridization-based Molecular Diagnostics Market Summary: According to the latest report published by Data Bridge Market Research, the Hybridization-based Molecular Diagnostics Market The global hybridization-based molecular diagnostics market size was valued at USD 2.85 billion in 2025 and is expected to reach USD 4.82 billion by 2033, at a CAGR of...0 Comments 0 Shares 75 Views 0 Reviews
-
Molecular Diagnostics And NAT Market: How Is Precision Medicine and Cancer Diagnostics Expanding NAT Applications?Cancer diagnostics expanding NAT applications — the emerging application of molecular diagnostics and nucleic acid detection technology to cancer diagnostics — including circulating tumor DNA (ctDNA) detection, minimal residual disease (MRD) monitoring through blood-based liquid biopsy, and tumor-specific mutation analysis — creating a premium diagnostics market segment whose...0 Comments 0 Shares 74 Views 0 Reviews
-
Molecular Diagnostics Market Outlook 2030: Size, Share, Forecast, and Emerging TrendsMolecular diagnostics refers to laboratory methods that analyze DNA, RNA, or proteins to detect disease. It helps in understanding disease mechanisms at a genetic level. This information guides effective treatment planning. Molecular Diagnostics Market In Depth Analysis and Growth Forecast to 2030 The Molecular Diagnostics Market was valued at US$ 18,173.87 million in 2022 and is...0 Comments 0 Shares 404 Views 0 Reviews
-
Multiplex Assays Market Trends in Molecular DiagnosticsThe Global Multiplex Assays Market is entering a transformative era, driven by the shift from traditional single-plex ELISA to high-throughput, multi-analyte testing. Multiplex assays allow for the simultaneous detection of several analytes (proteins, nucleic acids, or cells) in a single cycle, significantly reducing sample volume, time, and costs. In 2024, the market was...0 Comments 0 Shares 249 Views 0 Reviews
-
North America Point-of-Care Molecular Diagnostics Market Insights for Healthcare StakeholdersThe North America Point-of-Care Molecular Diagnostics market continues to play a significant role in the global healthcare diagnostics landscape. The region benefits from advanced healthcare infrastructure, increasing adoption of rapid diagnostic technologies, and a strong focus on improving patient outcomes through timely disease detection. Healthcare providers across North America are...0 Comments 0 Shares 41 Views 0 Reviews
-
DNA Microarray Chips Market Statistics, Share and Industry OutlookThe DNA microarray chips market is witnessing substantial growth due to the increasing demand for advanced genomic analysis, personalized medicine, and molecular diagnostics. DNA microarray technology enables researchers and healthcare professionals to analyze thousands of genes simultaneously, making it a critical tool in genetic research, disease diagnosis, drug discovery, and biomarker...0 Comments 0 Shares 125 Views 0 Reviews
-
Global In Vitro Diagnostic (IVD) Quality Control Market: Strategic Trends and Report Scope (2022–2030)In the high-stakes world of clinical diagnostics, the margin for error is virtually zero. In Vitro Diagnostic (IVD) Quality Control (QC) refers to the specialized materials, software, and services used to validate the reliability of diagnostic testing systems. Whether it is a blood glucose monitor at a patient’s bedside or a high-throughput molecular analyzer in a reference lab, QC...0 Comments 0 Shares 690 Views 0 Reviews
-
Global Nuclear Medicine Market to Reach USD 40.19 Billion by 2033, Growing at 11.20% CAGRThe global nuclear medicine market size was valued at USD 15.46 billion in 2024 & it is projected to reach from USD 17.19 billion in 2025 to USD 40.19 billion by 2033, growing at a CAGR of 11.20% during the forecast period (2025–2033). Market Overview The global Nuclear Medicine market is witnessing swift transformation driven by new consumer...0 Comments 0 Shares 1K Views 0 Reviews
-
Global PCR Technologies Market Forecast and Growth Analysis to 2030The global PCR technologies market is experiencing steady expansion, driven by increasing applications in diagnostics, research, and personalized medicine. The PCR technologies market size is projected to reach US$ 24,524.50 million by 2030 from US$ 13,101.87 million in 2022, reflecting a CAGR of 8.2% during the forecast period from 2022 to 2030. This growth is largely attributed to the rising...0 Comments 0 Shares 221 Views 0 Reviews
-
Precision Cancer Diagnostic Tests Market Expansion Across Liquid Biopsy ApplicationsThe global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...0 Comments 0 Shares 191 Views 0 Reviews
More Results